| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.2 | 6e-10 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.2 | 7e-10 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.18 | 8e-09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.19 | 9e-09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.29 | 1e-08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.29 | 1e-07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.28 | 2e-07 |